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Abstract 
 
Hox genes play important roles in the specification of spatial identity during 
development of vertebrate embryos.  Retinoic acid regulates the transcription of Hox genes 
in vertebrates.  We identified an epidermal enhancer in the 5' flanking region of an ortholog 
of Hox1 (Ci-Hox1) in the ascidian Ciona intestinalis.  This enhancer element drives the 
transcription of a lacZ reporter gene in the epidermis in the posterior trunk and the anterior 
tail region of tailbud-stage embryos.  Inhibition of retinoic acid synthesis resulted in 
inactivation of the expression of the reporter gene.  The enhancer contains a putative retinoic 
acid response element.  When this element was mutagenized, the expression of the reporter 
gene disappeared from the epidermis.  This sequence was also required for the response to 
exogenously administered retinoic acid.  A heterodimeric nuclear receptor, consisting of the 
retinoic acid receptor and retinoid X receptor, bound to this sequence.  These results indicate 
that retinoic acid directly activates the epidermal enhancer of Ci-Hox1.  This is the first 
demonstration that retinoic acid is necessary for endogenous gene expression in ascidian 
embryos.   
(173 words) 
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Introduction 
 
Animals belonging to the phylum Chordata are characterized by a notochord, a 
dorsally located neural tube and a pharynx with gill slits (Gee, 1996).  Among chordates, 
ascidians, salps and larvaceans comprise a unique sub-phylum, Urochordata.  The body plan 
of their tadpole-type larvae is greatly simplified but still retains the essence of 
chordate-specific features (Satoh and Jeffery, 1995; Di Gregorio and Levine, 1998).  
Therefore, urochordates are a suitable model system with which to study the evolution of the 
molecular mechanisms that establish the chordate-specific architecture of the body.  Since 
retinoic acid (RA) seems to play important developmental roles only in chordates, it is 
proposed that the acquisition of RA-dependent developmental programs was a key event 
during the evolution of chordates (Fujiwara and Kawamura, 2003; Fujiwara, 2006). 
RA is necessary for morphogenesis in vertebrate embryos.  This was clearly 
demonstrated by targeted mutagenesis of genes encoding retinoic acid receptors (RARs) and a 
retinoic acid-synthesizing enzyme, RALDH2 (Lohnes et al., 1994; Mendelsohn et al., 1994; 
Niederreither et al., 1999).  Particularly, RA regulates the formation of chordate-specific 
organs and tissues, including the neural tube, pharynx (branchial arches), paired limbs, and 
neural crest cells (for reviews see Fujiwara and Kawamura, 2003; Campo-Paysaa et al., 2008).  
RAR forms a heterodimer with retinoid X receptor (RXR), and binds to a specific DNA 
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sequence called the RA response element (RARE) within the enhancer region of target genes 
(Umesono et al., 1991; Bastien and Rochette-Egly, 2004).  Hox genes are important targets 
of RA signaling (Krumlauf et al., 1993; Marshall et al., 1996; Altman and Brivanlou, 2001).  
Enhancer regions of Hox genes contain RAREs and a normal expression depends on RA 
(Marshall et al., 1996).  Three major chordate groups (vertebrates, urochordates and 
cephalochordates) possess RALDH2, RARs, and an RA-degrading cytochrome P450 enzyme 
(CYP26) (Cañestro et al., 2006).  Although genes encoding these proteins have been found 
in lophotrochozoans (mollusks and annelids), the morphogenetic role of RA seems restricted 
to neurite outgrowth in these taxa (Campo-Paysaa et al., 2008).  Therefore, the connection of 
RAR to Hox enhancer elements would have been a crucial event in the evolution of the 
chordate body plan. 
In cephalochordate embryos, exogenously administered RA interfered with 
pharyngeal morphogenesis (Holland and Holland, 1996), differentiation of epidermal neurons 
(Schubert et al., 2004a), and patterning of the central nervous system (Schubert et al., 2006).  
An RA antagonist had opposite effects, suggesting that endogenous RA signaling is required 
for normal embryonic development (Schubert et al., 2004a, 2004b, 2006).  Hox1 plays a key 
role in mediating the actions of RA in most of these cases (Schubert et al., 2004b, 2006).  
The amphioxus Hox1 gene (AmphiHox-1) contains a functional RA response element (RARE) 
within its enhancer located in the 3' flanking region (Manzanares et al., 2000; Wada et al., 
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2006).  The AmphiHox-1 enhancer directs reporter gene expression in the hindbrain and 
neural crest cells in embryos of chicks and mice (Manzanares et al., 2000).  Recent extensive 
phylogenetic analyses revealed that cephalochordates diverged earlier during the evolution of 
chordates, and urochordates are the closest relatives of vertebrates (Delsuc et al., 2006, 2008).  
Therefore, the pivotal role of RA in cephalochordates indicates that hard wiring of the 
RAR-Hox regulatory machinery had already been established in the common chordate 
ancestor. 
In contrast to the case in cephalochordates, RA does not have a severe effect on 
morphogenesis in the embryo of the larvacean Oikopleura dioica, which belongs to the 
urochordates (Cañestro and Postlethwait, 2007).  RA did not affect the expression pattern of 
Hox1 or any other gene examined (Cañestro and Postlethwait, 2007).  The compact genome 
of this species does not contain Raldh2, RAR, and Cyp26 (Cañestro et al., 2006).  Thus, 
Cañestro and Postlethwait (2007) proposed that the regulatory input from RAR to Hox was 
disconnected early on in the evolution of the urochordate lineage. 
The urochordate ascidian Ciona intestinalis is an emerging model system for 
studying embryonic development (Satoh, 2003).  In this species, exogenously administered 
RA enhances the expression of a variety of genes, including Ci-Hox1 (Ishibashi et al., 2003, 
2005; Nagatomo et al., 2003).  Therefore, the RA signaling machinery is highly active in the 
C. intestinalis embryo, unlike the O. dioica embryo.  The C. intestinalis genome contains a 
 
-6- 
single Hox1 gene, named Ci-Hox1 (Dehal et al., 2002; Ikuta et al., 2004).  Ci-Hox1 is 
expressed around the neck region and visceral ganglion of the nerve cord and in a restricted 
area of the epidermis (Nagatomo and Fujiwara, 2003; Ikuta et al., 2004; Ikuta and Saiga, 
2007; Imai et al., 2009).  The epidermal Ci-Hox1 expression domain encompasses the 
posterior trunk to the anterior tail (Nagatomo and Fujiwara, 2003).  RA treatment activates 
Ci-Hox1 expression in the entire epidermis (Nagatomo and Fujiwara, 2003).  A microarray 
analysis revealed that the RA-induced activation occurred in the absence of translation, 
suggesting that pre-existing RAR directly activates the enhancer of Ci-Hox1 (Ishibashi et al., 
2005).  Knockdown of Raldh2 using a specific morpholino oligonucleotide diminished the 
expression of Ci-Hox1, indicating that endogenous RA is essential for the Ci-Hox1 expression 
(Imai et al., 2009).  Despite the circumstantial evidence, no RARE has ever been identified 
in the enhancer regions of Ci-Hox1 or other targets in C. intestinalis.  It has been unclear 
whether the expression of these genes requires the endogenous RA signal in normal embryos. 
In the present study, we identified an epidermal enhancer of Ci-Hox1 within the 5' 
flanking region.  We demonstrated that the Ci-RAR/Ci-RXR heterodimer binds to an RARE 
found in the enhancer.  Mutation of this RARE diminished Ci-Hox1 expression in the 
epidermis, suggesting that RAR-mediated RA signaling directly activates Ci-Hox1 expression 
in the epidermis of normal C. intestinalis embryos.   
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Materials and methods 
 
Animals 
 
C. intestinalis juvenile adults were kindly provided by Kazuko Hirayama and Nori 
Satoh at Kyoto University, through the National Bio-Resource Project of MEXT, Japan.  
They were cultured in Tosa Bay near the Usa Marine Biological Institute.  Eggs and sperm 
were surgically obtained from the gonoducts.  Eggs were inseminated with non-self sperm.  
Fertilized eggs were dechorionated with 0.05% actinase E (Kaken Pharm., Tokyo, Japan) and 
1% sodium thioglycolate.  The embryos were raised in agarose-coated Petri dishes. 
 
Transgenes 
 
 Genomic DNA corresponding to the 5' flanking region of Ci-Hox1 was amplified by 
polymerase chain reaction (PCR) using the primers 1.0F 
(5'-TAGATTGATGATTCAATATGAGGAACGTAATTTCG-3') and 1.0R 
(5'-ACCGGGTATTCTAGATACGAATTCATCTTACACCT-3').  The italicized sequence in 
1.0R corresponds to the translation initiation site located within the second exon (Fig. 1A).  
The PCR product was inserted into pGEM-T (Promega, Madison, WI), and then excised with 
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XhoI and XbaI.  The recognition site of XhoI was located within the 5' flanking sequence 
(Fig. 1A), while that of XbaI was the underlined sequence in 1.0R.  This DNA fragment was 
inserted into the vector pSP72-1.27 (Corbo et al., 1997) digested with XhoI and XbaI.  The 
resulting plasmid was named Ci-Hox1(1.0)/lacZ.  The second intron of Ci-Hox1 was 
amplified by PCR, using 5'-CACCGGCTAGCAGTAAGTTGTAAAGTTTAACA-3' and 
5'-CCATACCCGGGACTAAAACAGACACAAAACATTGT-3'.  The product of the PCR 
was inserted into pGEM-T.  A 1.9-kb central region of the intron was excised with SalI and 
XmnI, the recognition sites of which were located within the intronic sequence (Fig. 1A).  
This fragment was then inserted into Ci-Hox(1.0)/lacZ digested with XhoI and NruI, whose 
recognition sites were located within the 5' flanking region (Fig. 1A).  The resultant plasmid 
was called Ci-Hox1(intron2)/lacZ.  Ci-Hox1(intron2)/lacZ was digested with BstBI and SpeI 
(Fig. 1A).  Cohesive ends created by these enzymes were blunted, using T4 DNA 
polymerase, and the circular plasmid was recovered by self-ligation.  The resultant plasmid 
was called Ci-Hox1(?BsSp)/lacZ.   
 For site-directed mutagenesis, the NcoI-SpeI fragment in Ci-Hox1(intron2)/lacZ was 
mutagenized as follows (see Figs 1A and 5A).  A DNA fragment was amplified by PCR 
using 5'-GTTTTGCTCCCATGGCCTCGATC-3' (NcoI site is underlined) and 
5'-GGTGAAAAtcTagaCGTTTGT-3' (XbaI site is underlined).  The lower case letters in the 
latter primer were not complementary to the native Ci-Hox1 sequence.  The product of the 
 
-9- 
PCR was inserted into pGEM-T.  This plasmid was named Mut-X.  Another DNA fragment 
was amplified by PCR using 5'-ACAAACGgctAgCTTTTCACC-3' (NheI site is underlined) 
and 5'-CTTTACCTACTAGTATAAAGC-3' (SpeI site is underlined).  The lower case letters 
in the former primer were not complementary to the native Ci-Hox1 sequence.  The product 
of the PCR was once inserted into pGEM-T, and then cut with NheI and SpeI.  This 
restriction fragment was inserted into Mut-X digested with XbaI and SpeI.  In this case, SpeI 
cut its recognition site within the vector sequence.  The cohesive ends produced by NheI and 
XbaI were ligated.  As a result, the putative RARE sequence, 5'-ATGAACTTTTCACCC-3' 
(underlines show putative binding sites for RAR and RXR), was mutagenized into 
5'-GCTAGATTTTCACC-3' (underline shows the NheI/XbaI junction).  After confirmation 
of the sequence, the mutagenized enhancer was excised from Mut-RARE with NcoI and SpeI, 
and replaced with the corresponding wild-type enhancer fragment in Ci-Hox1(intron2)/lacZ. 
For construction of Ci-Hox1(0.9)/lacZ, genomic DNA corresponding to the 5' 
flanking region of Ci-Hox1 was amplified by PCR using the primers 0.9F 
(5'-GGGGTCGACGAACGATCATCATGCCAACAT-3') and 0.9R 
(5'-GGGGATCCTGCGGGGTGATGTGGTTGGTAT-3').  The amplified DNA fragment was 
digested with SalI and BamHI (underlined sequences in 0.9F and 0.9R, respectively) and 
inserted into pSP72-1.27.  For construction of Ci-Hox1(del1)/lacZ, two different parts of the 
Ci-Hox1 5' flanking region were separately amplified by PCR.  The primers used were 0.9F 
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and 0.9-del1-R (5'-GGGTCTAGATCCAATTTTAATATAAGAAAC-3') for the 5' fragment, 
and 0.9-del1-F (5'-GGGTCTAGATGTGACCGGACACTGGAAACA-3') and 0.9R for the 3' 
fragment.  The recognition sites of XbaI are underlined.  The 5' fragment was digested with 
SalI and XbaI, while the 3' fragment was digested with XbaI and BamHI.  These fragments 
were inserted one by one into pSP72-1.27.  As a result, a conserved sequence (element 1; see 
Fig. 4B, C) in the 5' flanking region of Ci-Hox1 was replaced by the recognition site of XbaI.  
Ci-Hox1(del2)/lacZ was constructed by a similar method, except that the primers 0.9-del-2R 
(5'-GGTCTAGAGCTTTCGGCGCGTTTCTCATTT-3') and 0.9-del2-F 
(5'-GGTCTAGAGCTGTTTTTACAAGATGAATAA-3') were used instead of 0.9-del1-R and 
0.9-del1-F, respectively.  As a result, another conserved sequence (element 2; see Fig. 4B, C) 
was replaced by the recognition site of XbaI.  Ci-Hox1(0.9)mut/lacZ was also made by a 
similar method, except that mutF (5'-GGGGCTAGCTTTTCACCCTAGAGTGAAGAC-3') 
and mutR (5'-GGGTCTAGACGTTTGTTTGCTTATTATCTT-3') were used instead of 
0.9-del1-F and 0.9-del1-R, respectively.  In this case, mutF contained the recognition 
sequence of NheI, while mutR contained the recognition sequence of XbaI.  Both of the 
DNA fragments were inserted into pSP72-1.27, where cohesive ends produced by NheI and 
XbaI were ligated.  In this construct, a DR2-type RARE (5'-TGAACTTTTCACCC-3') was 
replaced by the sequence (5'-ctagCTTTTCACCC-3') (see Fig. 4B-D). 
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Electroporation, drug administration, and detection of the expression of reporter genes 
 
A large-scale preparation of plasmid DNA was carried out using QIAGEN tip-100 
(QIAGEN, Valencia, CA).  The plasmid DNA was dissolved in 500 ?l of 0.77 M mannitol at 
a concentration of 60??g/ml.  The plasmid DNA was introduced into dechorionated embryos 
by electroporation as described by Corbo et al. (1997). 
Electroporated embryos were treated with 1 ?M all-trans RA (Sigma-Aldrich, St. 
Louis, MO) in the presence or absence of 200 ?g/ml of puromycin (Sigma-Aldrich) for 1 h 
from the neurula stage.  As a control, embryos were treated with 0.1% dimethylsulfoxide 
(DMSO), since the 1 mM RA stock was dissolved in DMSO.  To inhibit RA synthesis, 
embryos were treated with 3,7-dimethyl-2,6-octadienal (citral) or 
4-dimethylaminobenzaldehyde (DEAB) from the 32-cell stage to the middle tail bud stage.  
As a control, embryos were treated with 0.1% DMSO or 0.1% ethanol, since the DEAB and 
citral stocks were dissolved in DMSO and in ethanol, respectively. 
For the detection of lacZ mRNA, embryos were fixed with a solution containing 4% 
paraformaldehyde, 100 mM MOPS (pH 7.5) and 500 mM NaCl.  Whole-mount in situ 
hybridization was performed essentially according to Mita and Fujiwara (2007), except that 
the immunological detection of hybridization signals was carried out using a buffer containing 
100 mM Tris-HCl (pH 7.5) and 150 mM NaCl, instead of phosphate-buffered saline.  For the 
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detection of ?-galactosidase activity, embryos were fixed with 0.75% formaldehyde at room 
temperature for 30 min.  The specimens were stained in seawater containing 120 ?g/ml of 
X-gal, 3 mM potassium ferrocyanide, 3 mM potassium ferricyanide, 1 mM MgCl2, 0.1% 
Tween20, and 0.75% formaldhyde.  For immunological detection of ?-galactosidase, 
embryos were fixed with 3.5% formaldehyde at 4ºC for 3 h.  The specimens were washed 
with phosphate-buffered saline containing 0.1% Triton X-100 (T-PBS), and were incubated at 
room temperature for 3 h in T-PBS containing 10% goat serum (Vector Laboratories, 
Burlingame, CA).  The specimens were reacted with a monoclonal anti-?-galactosidase 
antibody (Promega) overnight at 4ºC.  After washing with T-PBS, the specimens were 
stained with an Alexa488-conjugated anti-mouse IgG raised in goat (Molecular 
probes-Invitrogen, Tokyo, Japan).  Fluorescent images were obtained using a C1si confocal 
microscope (Nikon, Tokyo, Japan). 
 
Electrophoretic mobility shift assay (EMSA) 
 
The entire translated region of Ci-RAR and Ci-RXR was obtained by PCR using KOD 
DNA polymerase (Toyobo, Osaka, Japan) and cDNA clones (ID citb035d16 and citb010c11, 
respectively) as templates (Satou et al., 2002).  The primers used for the amplification of 
Ci-RAR were AF (5'-TGAACGTTATGGAGTTTCAAGAACA-3') and AR 
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(5'-ACGAGGCTAGCTTATTCGACCTCGT-3'), while those for Ci-RXR were XF 
(5'-CATTGCCAACTACGGGGAATGGTTT-3') and XR 
(5'-CAGTGGCTAGCTCACAGGTTGGCGA-3').  Italicized sequences in AR and XR 
correspond to stop codons.  The recognition site of NheI is underlined.  The products of the 
PCR were digested with NheI.  These DNA fragments were inserted into pCMX-hRAR? 
(Umesono et al., 1991) digested with MscI and NheI.  The resultant plasmids were named 
pCMX-Ci-RAR and pCMX-Ci-RXR, respectively.  Using these plasmids as templates, the 
Ci-RAR and Ci-RXR proteins were produced, according to the protocol for the TNT-coupled 
Reticulocyte Lysate Systems (Promega). 
The double-stranded DNA probe, named Ci-Hox1-DR2, was prepared by annealing 
the complementary oligonucleotides, 5'-AACAAACGATGAACTTTTCACCCTAGAGTG-3' 
and 5'-TTCACTCTAGGGTGAAAAGTTCATCGTTTG-3', where sequences corresponding 
to a putative RARE are underlined.  The probe, named Ci-Hox1-DR2mut, was prepared by 
annealing the oligonucleotides, 5'- AACAAACGtctagCTTTTCACCCTAGAGTG-3' and 
5'-TTCACTCTAGGGTGAAAAGctagaCGTTTG-3'.  Lower case letters indicate 
mutagenized sites.  The 5' end of both strands was labeled with a Redivue [?-32P] adenosine 
triphosphate (GE healthcare, Buckinghamshire, UK).  In vitro translated proteins and labeled 
double-stranded DNA probes were incubated in a binding buffer for 20 min at room 
temperature.  The binding buffer contained 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 0.5 mM 
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DTT, 4% glycerol, 0.5 mM EDTA, 1 mM MgCl2, 0.05 mg/ml of poly (dI-dC)?poly (dI-dC), 
0.5 mM ZnCl2, and 0.2 ?M all-trans retinoic acid.  A 50-fold excess of unlabeled competitor 
DNA was added to the reaction buffer.  As a non-specific competitor, the AP2 
oligonucleotide supplied in the Gel Shift Assay System (Promega) was used.  The 
autoradiogram was obtained using a BAS-2500 IP Reader (Fujifilm, Tokyo, Japan). 
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Results 
 
An epidermal enhancer of Ci-Hox1 is located within the 5' flanking region 
 
The C. intestinalis genome contains a single Hox1 gene (Ikuta et al., 2004).  The 
Ci-Hox1 gene consists of four exons (Fig. 1A).  A putative translation initiation site is 
located within the second exon (Fig. 1A).  The nucleotide sequence of Ci-Hox1 was 
compared with that of the ortholog of Hox1 in a related ascidian species, Ciona savignyi, 
using the VISTA Genome Browser (http://genome.lbl.gov/vista/index.shtml).  We found a 
few blocks of conserved sequences within the 3.5-kb second intron (data not shown).  We 
constructed a reporter gene, named Ci-Hox1(intron2)/lacZ, in which lacZ was fused 
downstream of the first 22 bp of the second exon (Fig. 1B).  It contained a genomic DNA 
fragment spanning from nucleotide position -894 (NruI site) to the first 11 bp of the translated 
region of Ci-Hox1 (Fig. 1B).  It also contained a 1.9-kb fragment, excised from the second 
intron with SalI and XmnI (Fig. 1B).  This fragment contained all the blocks of conserved 
sequences.  Since the intronic fragment did not contain the 5' and 3' splice sites, it was fused 
upstream of the 5' flanking region (Fig. 1B).  The transgene was introduced into one-cell 
embryos by electroporation, and the expression of lacZ was visualized by the histochemical 
staining of ?-galactosidase activity (Fig. 1C).  Ci-Hox1(intron2)/lacZ was expressed in the 
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epidermis and neural tube.  Epidermal expression was restricted to the posterior half of the 
trunk and the anterior third of the tail in tailbud stage embryos (Fig. 1C).  A fluorescent 
staining using a ?-galactosidase-specific antibody revealed that the expression in the neural 
tube was restricted to the neck, visceral ganglion and anterior nerve cord regions (Fig. 1C').  
This pattern of expression was similar to that of endogenous Ci-Hox1, although the 
expression domain of the reporter gene seemed slightly wider than that of the endogenous 
gene (Nagatomo and Fujiwara, 2003).  The expression of Ci-Hox1(intron2)/lacZ was 
activated by 1 ?M all-trans RA in the entire epidermis (Fig. 1E).  DMSO, the solvent used to 
make the stock solution of RA, did not affect the pattern of expression of the reporter gene 
(Fig. 1D).  The DNA fragment between the SpeI site (nucleotide position -118) and BstBI 
site in the intronic sequence was deleted from Ci-Hox1(intron2)/lacZ (Fig. 1B).  The 
resultant plasmid, named Ci-Hox1(?BsSp)/lacZ, lost 775 bp of the 5' flanking region and 41 
bp of intronic sequence through this deletion (Fig. 1B).  The epidermal expression of 
Ci-Hox1(?BsSp)/lacZ was much weaker than that of Ci-Hox1(intron2)/lacZ (Fig. 1F).  In 
contrast, the expression of Ci-Hox1(?BsSp)/lacZ in the neural tube was not affected (Fig. 1F).  
Although RA enhanced the expression of Ci-Hox1(?BsSp)/lacZ in the epidermis to some 
extent, the responsiveness to RA was severely affected (Fig. 1G).  The expression of 
Ci-Hox1(?BsSp)/lacZ in the neural tube seemed slightly upregulated by RA (Fig. 1G).  
However, this was not clear because the anterior neural tube did not close and its constituent 
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cells remained outside and were not regularly arranged in the RA-treated embryo (Nagatomo 
et al., 2003; Fig. 1G).  The results suggest that the 5' flanking region contains an enhancer 
element important for activation in the epidermis.  We focused our attention mainly on this 
epidermal enhancer element. 
 
The epidermal enhancer of Ci-Hox1 is directly activated by RA 
 
The response of the epidermal enhancer to RA was examined by simultaneously 
treating electroporated embryos with 1 ?M RA and 200 ?g/ml of a translational inhibitor, 
puromycin.  Drug treatment was performed for 1 hour at the neurula stage just before the 
endogenous Ci-Hox1 gene starts to be expressed.  The expression of lacZ mRNA was 
detected by in situ hybridization.  Ci-Hox1(intron2)/lacZ was expressed in the epidermis and 
neural tube in DMSO-treated control embryos (Fig. 2A).  All-trans RA activated the 
expression of Ci-Hox1(intron2)/lacZ in all epidermal cells, irrespective of the presence of 
puromycin (Fig. 2B and C).  In contrast, RA did not activate the expression of 
Ci-Hox1(?BsSp)/lacZ in the epidermal cells (Fig. 2D-F).  These results suggest that no 
protein synthesis is necessary for the RA-dependent activation of the epidermal enhancer of 
Ci-Hox1.  This means that the RAR/RXR heterodimer binds and directly activates the 
enhancer. 
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Activation of the epidermal enhancer of Ci-Hox1 requires endogenous RA 
 
To investigate whether endogenous RA is necessary for the activation of the 
epidermal enhancer of Ci-Hox1, we tested the effect of inhibitors of RA synthesis (citral and 
DEAB) on the expression of Ci-Hox1(intron2)/lacZ.  Embryos carrying 
Ci-Hox1(intron2)/lacZ were treated with citral or DEAB (Fig. 3).  Citral affected retinal 
development in zebrafish at 50~250 ?M (Marsh-Armstrong et al., 1994).  DEAB caused 
specific morphogenetic defects in zebrafish embryos at 50~100 ?M (Kopinke et al., 2006).  
Since these drugs have never been used for ascidians, we treated the C. intestinalis embryo at 
various concentrations.  Citral and DEAB inhibited the expression of Ci-Hox1(intron2)/lacZ 
in a dose-dependent manner (Fig. 3).  The expression was affected in both the epidermis and 
neural tube (Fig. 3).  These results suggest that the activation of the CiHox1 enhancer needs 
endogenous RA.  Since the development of citral-treated and DEAB-treated embryos 
seemed to be delayed (Fig. 3), we examined the expression of Ci-Hox1(intron2)/lacZ at later 
stages.  However, the expression was not activated in the later stage embryos (data not 
shown). 
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An RARE-like sequence is necessary for the activity of the epidermal enhancer of Ci-Hox1 
 
The nucleotide sequence of the 5' flanking region of Ci-Hox1 was compared with 
that of the C. savignyi Hox1 gene (Cs-Hox1), using the VISTA Genome Browser (Fig. 4A).  
We found two blocks of conserved sequences, named elements 1 and 2 (Fig. 4A).  Element 2 
contained a sequence similar to the consensus RARE (Fig. 4B).  Typical RARE sequences 
are direct repeats of two half sites to which RAR and RXR bind (Umesono et al., 1991).  
The half sites (5'-AGGTCA-3' or sequences similar to it) are usually separated by two or five 
nucleotides.  They are called DR2 and DR5, respectively.  The complementary strand of the 
RARE-like sequence in element 2 (5'-GGGTGAaaAGTTCA-3') resembled DR2 (Fig. 4B).  
This nucleotide sequence was completely conserved in the corresponding region of the C. 
savignyi genome (Fig. 4C).  To assess the activity of elements 1 and 2, we constructed a 
reporter gene, where lacZ was placed downstream of a genomic DNA fragment spanning 
from nucleotide position -853 (SalI site) to the putative translation initiation site (Fig. 4D).  
The reporter gene, named Ci-Hox1(0.9)/lacZ, contained the elements 1 and 2 (Fig. 4D).  It 
did not contain the intronic sequence.  The expression of Ci-Hox1(0.9)/lacZ was mainly 
observed in the epidermis (Fig. 4D, Table 1).  The epidermal expression was restricted to the 
posterior half of the trunk and the anterior third of the tail region (data not shown).  This 
pattern of epidermal expression was similar to that obtained with Ci-Hox1(intron2)/lacZ.  
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However, no expression was observed in the neural tube (Table 1).  Considering the 
expression pattern of Ci-Hox1(?BsSp)/lacZ, a neural tube enhancer is thought to be located 
within the second intron (Figs 1F and 2D).  We generated an internal deletion of element 1 
or element 2 of Ci-Hox1(0.9)/lacZ (Fig. 4D).  The pattern of expression of 
Ci-Hox1(del1)/lacZ, which did not contain element 1, was indistinguishable from that of 
Ci-Hox(0.9)/lacZ (Table 1).  Ci-Hox1(del2)/lacZ did not contain element 2 (Fig. 4D).  No 
expression of lacZ mRNA was observed in the epidermis of the embryo carrying 
Ci-Hox1(del2)/lacZ (Table.1).  Ci-Hox1(0.9)mut/lacZ contained point mutations in the 
RARE-like sequence (Fig. 4D, E).  The expression of Ci-Hox1(0.9)mut/lacZ was not 
detected in the epidermis (Table 1).  These results indicate that the DR2-type RARE-like 
sequence in element 2 is necessary for the activation of the epidermal enhancer of Ci-Hox1 in 
normal embryos. 
To confirm that the RARE-like sequence in element 2 was specifically required for 
the epidermal enhancer, we generated the same mutation in Ci-Hox1(intron2)/lacZ (Fig. 5A).  
The resultant reporter gene was named Ci-Hox1(intron2)mut/lacZ (Fig. 5A).  As described 
above, Ci-Hox1(intron2)/lacZ was expressed in the epidermis and neural tube (Fig. 5B; see 
also Fig. 1C, C', D).  RA strongly activated the expression of Ci-Hox1(intron2)/lacZ in the 
entire epidermis (Fig. 5C; see also Fig. 1E).  In contrast, Ci-Hox1(intron2)mut/lacZ was 
expressed exclusively in the neural tube in normal embryos (Fig. 5D).  The expression in the 
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neural tube served as an internal control, indicating that the embryos carried a sufficient 
amount of transgenes.  RA did not strongly induce the expression of 
Ci-Hox1(intron2)mut/lacZ in the epidermis (Fig. 5E).  Thus, the RARE-like sequence in 
element 2 is important for the activation in the epidermis of normal embryos and the 
responsiveness to RA.  The results also revealed that the RARE-like sequence is not required 
for the activation of the neural tube enhancer. 
 
The RAR/RXR heterodimer binds to the RARE-like sequence. 
 
We used an EMSA to test whether the RAR/RXR heterodimer binds the putative 
DR2-type RARE of Ci-Hox1.  In vitro synthesized Ci-RAR, Ci-RXR and TC14-3 proteins 
were used for EMSA.  TC14-3 was used as a control protein.  TC14-3 is a 
galactose-binding Ca
2+
-dependent lectin, whose cDNA clone was isolated from the budding 
ascidian Polyandrocarpa misakiensis (Matsumoto et al., 2001).  An oligonucleotide probe 
was designed to contain the putative RARE found in the 5' flanking region of Ci-Hox1.  The 
probe was called, Ci-Hox1-DR2.  A DNA/protein complex was formed when Ci-Hox1-DR2 
was added to the reaction mixture containing Ci-RAR and Ci-RXR (Fig. 6, lane 3).  No 
shifted band was observed when Ci-Hox1-DR2 was mixed with either Ci-RAR or Ci-RXR 
only (Fig. 6, lanes 1 and 2).  TC14-3 did not form a complex with Ci-Hox1-DR2 (Fig. 6, 
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lane 4).  The complex's formation was inhibited with a 50-fold molar excess of unlabeled 
CiHox1-DR2, but not with an oligonucleotide containing an AP2-binding sequence (Fig. 6, 
lanes 6 and 7).  Another probe, named Ci-Hox1-DR2mut, was prepared, which contained 
point mutations within the putative RAR-binding sequence of Ci-Hox1-DR2.  
Ci-Hox1-DR2mut did not form a complex with a mixture of Ci-RAR and Ci-RXR proteins 
(Fig. 6, lane 5).  The results indicate that the DR2-like sequence in the 5' flanking region of 
Ci-Hox1 is a genuine RARE that binds the Ci-RAR/Ci-RXR heterodimer. 
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Discussion 
 
Epidermal expression of Ci-Hox1 is activated by RA 
 
In the present study, we identified an epidermal enhancer, lying within the 5' flanking 
region of the Ci-Hox1 gene.  We found an RARE within the enhancer region.  The Ci-RAR 
and Ci-RXR proteins bind this RARE.  Since neither of these proteins formed a 
protein/DNA complex, Ci-RAR and Ci-RXR probably bind this sequence as a heterodimer.  
Deletion or point mutation of the RARE sequence impaired the enhancer activity, suggesting 
that the binding of Ci-RAR and Ci-RXR to this sequence is necessary.  This, in turn, 
suggests that the RA signal is required to activate the epidermal enhancer of Ci-Hox1 in 
normal embryos.  This was supported by the results that the inhibition of RA synthesis by 
citral and DEAB diminished the activity of the enhancer.  These findings are consistent with 
previous observations that RA activated the expression of endogenous Ci-Hox1 gene even in 
the presence of puromycin (Ishibashi et al., 2005).  The present study provides the first direct 
evidence that ascidian RAR and RXR proteins activate the enhancer of a target gene in 
response to the endogenous RA signal.  Since the larvacean, O. dioica, does not contain an 
RAR-encoding gene in its genome, Cañestro and Postlethwait (2007) suggested that an 
RAR-independent pathway (e.g. protein kinase C-dependent signal transduction pathway) is 
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involved in the response of the Ci-Hox1 gene to RA.  However, the input from Ci-RAR to 
Ci-Hox has not been disconnected during the evolution of the ascidian lineage of the 
chordates.  The RA-independent mechanism of establishing the tadpole-type larval body 
plan was possibly acquired as a derivative feature in the larvacean ancestor. 
 
Epidermis-specific function of the RARE 
 
The Ci-Hox1(?BsSp)/lacZ reporter gene was expressed in the neural tube, although 
this gene did not contain the RARE in the 5' flanking region.  This result suggests that the 
RARE, found in the present study, is not necessary for the activation of the neural tube 
enhancer that is probably located within the second intron of the Ci-Hox1 gene.  However, 
Imai et al. (2009) showed that an Raldh2-specific morpholino oligonucleotide suppressed the 
expression of Ci-Hox1 in the neural tube.  Correspondingly, the present study showed that 
the expression of Ci-Hox1(intron2)/lacZ was also diminished in the neural tube by citral and 
DEAB.  The expression of Ci-Hox1(?BsSp)/lacZ seemed slightly enhanced in the neural 
tube, although it was difficult to estimate the level of enhancement because of the impaired 
arrangement of the neural tube cells in RA-treated embryos.  These observations could be 
explained by the existence of another RARE within the neural tube enhancer.  The 3' 
flanking region of the murine Hoxb1 gene contains two RARE sequences (Marshall et al., 
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1994; Huang et al., 1998).  One of them is required for the expression in the neural 
epithelium, and the other is responsible for the expression in the foregut (Marshall et al., 
1994; Huang et al., 1998).  Ogura and Evans (1995) revealed that two RARE sequences in 
the Hoxb1 enhancer were accompanied in close proximity by distinct transcription 
factor-binding sites.  Tissue-specific transcription factors are thought to occupy either site 
and modulate the activity of the RAR/RXR heterodimer, bringing about the tissue-specific 
function of the RARE sequences (Ogura and Evans, 1995).  The same binding site for the 
Drosophila Dorsal protein mediates transcriptional activation and repression in a 
context-dependent manner (Pan and Courey, 1992).  It is therefore reasonable to think that 
another RARE is located within the neural tube enhancer of Ci-Hox1, and mediates the neural 
tube-specific function of the Ci-RAR/Ci-RXR heterodimer.  Further detailed analyses are 
necessary for characterization of the neural tube enhancer of Ci-Hox1. 
 
Another pathway of RA-dependent transactivation of Ci-Hox1 in the epidermis 
 
The Ci-Hox1(?BsSp)/lacZ reporter gene did not lose all sensitivity to exogenously 
administered RA, even though it lacked the RARE.  However, the response of 
Ci-Hox1(?BsSp)/lacZ to RA was suppressed by puromycin.  These observations suggest that 
the regulatory region of Ci-Hox1 contains another sequence element responsible for an 
 
-26- 
indirect response to RA.  A plausible hypothesis is that the Ci-RAR/Ci-RXR heterodimer 
activates the transcription of a gene X, whose protein product activates the expression of 
Ci-Hox1.  In this case, puromycin can diminish the expression of Ci-Hox1 by inhibiting the 
translation of the X mRNA.  In vertebrates, cdx1 is a direct target of RAR (Houle et al., 
2000).  The enhancer region of cdx1 contains an RARE that is required for normal 
expression (Houle et al., 2000, 2003).  The spatial expression of various Hox genes is 
directly or indirectly regulated by Cdx (Houle et al., 2003; Gaunt et al., 2004).  Imai et al. 
(2009) revealed that FGF8/17/18 activates the expression of Ci-Hox1 in the neck region of the 
neural tube.  However, it is unclear whether RA is involved in this genetic cascade (Imai et 
al., 2009). 
 
Evolution of the epidermal enhancer of Hox1 in the chordates. 
 
Epidermal expression of Hox1 is also observed in the amphioxus Branchiostoma 
floridae (Holland and Garcia-Fernàndez, 1996) and the hemichordate Saccoglossus 
kowalevskii (Lowe et al., 2003).  Epidermal expression of Hox1 is a common feature of 
non-vertebrate deuterostomes.  RA is involved in the region-specific expression of the 
amphioxus Hox1 (Schubert et al., 2004a).  RA also affected the pattern of expression of 
genes in epidermal sensory neurons (Schubert et al., 2004a).  Since epidermal sensory 
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neurons in the C. intestinalis larva show a well-organized spatial pattern (Takamura, 1998; 
Pasini et al., 2006), it is of interest whether this pattern is regulated by Ci-RAR and Ci-Hox1. 
The epidermal expression of Hox1 is regulated by RA in B. floridae (Schubert et al., 
2004a).  The present finding that the epidermal expression of Hox1 is also regulated by RA 
during Ciona embryogenesis, strongly supports the homology of Hox1's epidermal expression 
between ascidian and amphioxus.  Because Hox1 is also expressed in the epidermis of S. 
kowalevskii, the expression of Hox1 in the epidermis likely predates the evolution of the 
neural tube (Lowe et al., 2003).  We provide evidence that in Ciona, the neural tube 
expression of Hox1 is regulated by a cis-regulatory element distinct from that for the 
epidermis, although both are dependent on RA.  Thus, the expression of Hox1 in the 
chordate neural tube was probably made possible by novel cis-regulatory elements.  In 
vertebrates, Hox gene expression is also observed in somitic and lateral plate mesoderm.  
The new Hox code in the mesoderm may have also been acquired through new cis-regulatory 
elements.  The elaborated body plan of vertebrates may have been established by this 
sequential co-opting of the Hox code. 
In this respect, it is of interest how the regulatory mechanism for the epidermal 
expression of Hox is retained in vertebrates.  Epidermal expression of vertebrate Hox1 is 
observed in the pharyngeal region.  The epidermal cells play essential roles in the patterning 
of the vertebrate pharynx, where Hox genes might be involved.  Alternatively, the epidermal 
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expression might be co-opted to the Hox code in the vertebrate neural crest, whose 
development is regulated by interaction between the neural tube and epidermis.  AP-2 is the 
only transcription factor proved to be specifically involved in the neural crest expression of 
the vertebrate Hox genes.  AP-2 is expressed in the entire epidermis in both ascidian and 
amphioxus.  The present study suggested that an epidermis-specific co-factor activates the 
epidermal enhancer of Ci-Hox1 synergistically with the RAR/RXR heterodimer.  AP-2 is a 
candidate for this co-factor, although it remains to be elucidated whether AP-2 is involved in 
the expression of Hox1 in the epidermis.  Identification of the ascidian epidermal factor 
cooperating with the RAR/RXR heterodimer will clarify the evolutionary history of the 
epidermal Hox code, and its contribution to the evolution of the vertebrate body plan. 
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Figure legends 
 
Fig. 1.  Characterization of an epidermal enhancer of Ci-Hox1.  (A)  The genomic 
structure of the Ci-Hox1 gene.  Exons are indicated by gray boxes.  The putative 
transcription start site is indicated by an arrow.  The putative translation initiation site is 
indicated by an arrowhead.  Recognition sites of restriction enzymes are also indicated.  Nc, 
NcoI; Nr, NruI; Sa, SalI; Sp, SpeI; Xh, XhoI; Xm, XmnI.  A part of the second intron, 
colored in red, was used for constructing the reporter constructs shown in (B).  (B)  
Diagrams show the reporter constructs containing the 5' flanking region and a fragment of 
intron 2 of Ci-Hox1.  Names of transgenes are on the right.  The intronic sequence is in red.  
The junction between the cohesive ends created by SalI and XhoI is indicated (Sa/Xh).  The 
junction between the blunt ends created by XmnI and NruI is also indicated (Xm/Nr).  (C-G)  
The expression pattern of transgenes, visualized by the histochemical staining of 
?-galactosidase activity.  The ?-galactosidase was immunologically detected in (C').  In all 
panels, the anterior side of the embryo is oriented to the left, with the dorsal side up.  ep, 
epidermis; nt, neural tube.  Insets show similar expression patterns observed in multiple 
specimens.  (C and C')  Nocrmal embryos carrying Ci-Hox1(intron2c)/lacZ.  (D)  
DMSO-treated control embryos carrying Ci-Hox1(intron2)/lacZ.  (E)  RA-treated embryos 
carrying Ci-Hox1(intron2)/lacZ.  (F)  DMSO-treated embryos carrying 
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Ci-Hox1(?BsSp)/lacZ.  (G)  RA-treated embryos carrying Ci-Hox1(?BsSp)/lacZ.  
 
Fig. 2.  Direct activation of the epidermal enhancer of Ci-Hox1 by RA.  The expression of 
reporter genes was detected by whole-mount in situ hybridization.  In all panels, the anterior 
side of the embryo is oriented to the left, with the dorsal side up.  ep, epidermis; nt, neural 
tube.  Insets show similar expression patterns observed in multiple specimens.  (A-C)  The 
pattern of expression Ci-Hox1(intron2)/lacZ.  (D-F)  The pattern of expression of 
Ci-Hox1(?BsSp)/lacZ.  (A and D)  DMSO-treated embryos.  (B and E)  Embryos 
simultaneously treated with RA and puromycin.  (C and F)  RA-treated embryos. 
 
Fig. 3.  Inhibition of RA synthesis affects the activity of the epidermal enhancer of Ci-Hox1. 
(A-D)  Expression of Ci-Hox1(intron2)/lacZ in citral-treated embryos.  (A)  
Ethanol-treated control embryos.  (B-D)  Embryos treated with 15 ?M (B), 20 ?M (C), or 
30 ?M (D) of citral.  (E-H)  Expression of Ci-Hox1(intron2)/lacZ in DEAB-treated 
embryos.  (E)  DMSO-treated control embryos.  (F-H)  Embryos treated with 150 ?M (F), 
200 ?M (G), or 250 ?M (H) of DEAB.  The expression of the reporter gene was detected by 
whole-mount in situ hybridization.  In all panels, the anterior side of the embryo is oriented 
to the left, with the dorsal side up.  nt, neural tube.  Insets show similar expression patterns 
observed in multiple specimens. 
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Fig. 4.  Conserved sequence elements in the 5' flanking region of the Hox1 genes in two 
related Ciona species.  (A)  Comparison of the 5' flanking region of Hox1 orthologs 
between C. intestinalis and C. savignyi by the Vista Genome Browser.  The first two exons 
of Ci-Hox1 are indicated by blue boxes.  The waveform represents the level of sequence 
similarity.  Two conserved regions are shown by a blue window (element 1) and an orange 
window (element 2).  (B)  Nucleotide sequence of a part of the 5' flanking region of 
Ci-Hox1.  Element 1 is shaded in blue, while element 2 is in orange.  A DR2-type 
RARE-like sequence is indicated by a red box.  (C)  Alignment of nucleotide sequence of 
element 2 (Ci-Hox1-element 2) with the corresponding region of the C. savignyi genome 
(Cs-Hox1-element 2).  The RARE-like sequence is indicated by a red box.  (D)  Diagrams 
show different 5' flanking regions used for the analysis summarized in Table 1.  Names of 
transgenes are on the right.  The mutagenized site is indicated by a red cross.  The exons of 
Ci-Hox1 are shown by gray boxes.  The transcription start site is indicated by an arrow.  
Two conserved sequence elements are indicated by a blue oval (element 1) and an orange oval 
(element 2).  The genomic structure of the Ci-Hox1 gene is indicated on the top.  (E)  
Comparison of the RARE-like sequence (DR2-type RARE) and its mutagenized form 
(DR2-type RARE mut). 
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Fig. 5.  The RARE-like sequence in the 5' flanking region of Ci-Hox1 is necessary for the 
activity of the epidermal enhancer.  (A)  Diagrams show Ci-Hox1(intron2)/lacZ and its 
mutagenized derivatives, named Ci-Hox1(intron2)mut/lacZ.  The exons of Ci-Hox1 are 
indicated by gray boxes.  The transcription start site is indicated by an arrow.  The 
mutagenized site is indicated by a red cross.  (B and C)  The pattern of expression of 
Ci-Hox1(intron2)/lacZ.  (D and E)  The pattern of expression of Ci-Hox1(intron2)mut/lacZ.  
(B and D)  DMSO-treated control embryos.  (C and E)  RA-treated embryos.  In all 
panels, the anterior side of the embryo is oriented to the left, with the dorsal side up.  ep, 
epidermis; nt, neural tube.  Insets show similar expression patterns observed in multiple 
specimens. 
 
Fig. 6.  Electrophoretic mobility shift assay.  Double-stranded 
32
P-labeled oligonucleotide 
probes (Ci-Hox1-DR2 and Ci-Hox1-DR2mut) were incubated with in vitro translated proteins 
(Ci-RAR, Ci-RXR or TC14-3).  DNA/protein complexes were fractioned on a 
polyacrylamide gel and visualized by scanning with a BAS-2500 IP Reader.  Proteins, 
radiolabeled probes, and competitors added to the reaction are indicated by (+) or (-) in each 
lane.  Signals indicating DNA/protein complexes are indicated by an arrow.  Arrowheads 
(NS) indicate non-specific signals.  Sequences of the probes are shown.  Lower case letters 
indicate mutagenized nucleotides. 
?????????????????????????????????? ????????????????????????????
Transgene name Epidermis Epidermis and ectopic Ectopic No expression N
CiHox1(0.9)/lacZ 28.1% 32.3% 18.8% 20.8% 96
CiHox1(del1)/lacZ 27.0% 44.3% 27.0% 1.7% 115
CiHox1(del2)/lacZ 0% 0% 84.2% 15.8% 57
CiHox1(0.9)mut/lacZ 0% 0% 96.3% 3.7% 82
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